Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Oct;12(5):433-40.
doi: 10.1007/s11920-010-0134-6.

Comparison of available treatments for tobacco addiction

Aryeh I Herman  1 , Mehmet Sofuoglu
Affiliations
Review

Comparison of available treatments for tobacco addiction

Aryeh I Herman et al. Curr Psychiatry Rep. 2010 Oct.

Abstract

Cigarette smoking is a major public health problem that causes more than 5 million deaths annually worldwide. Cigarette smoking is especially common among individuals with psychiatric comorbidity, including individuals with primary psychiatric disorders and other addictions. Effective behavioral and pharmacologic treatments for smoking cessation are available. Behavioral treatments including brief (< 3 min) counseling by physicians are effective. Seven first-line pharmacologic treatments are currently available: five nicotine replacement therapies, bupropion, and varenicline. In addition, clonidine and nortriptyline are second-line treatments for smoking cessation. These treatments increase the chances of quitting smoking by two- to threefold, supporting their use in smokers who are motivated to quit. However, effective treatments for many subpopulations, including smokers with psychiatric comorbidities as well as adolescent, pregnant, or postpartum smokers, remain to be developed and represent an important challenge.

PubMed Disclaimer

References

    1. Thorne SL, Malarcher A, Maurice E, Caraballo R. Cigarette smoking among adults—United States, 2007. JAMA. 2009;301:373–375.
    1. Grant BF, Hasin DS, Chou SP, et al. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2004;61:1107–1115. - PubMed
    1. Fiore MC, Jaén CR, Baker TB, et al. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services, Public Health Service; 2008. Treating Tobacco Use and Dependence: 2008 Update. The clinical practice guidelines are the main resource for treating individuals with tobacco use and dependence. The guidelines are based on the review of literature for most evidence-based treatments.
    1. Le Foll B, Wertheim C, Goldberg SR. High reinforcing efficacy of nicotine in non-human primates. PLoS One. 2007;2:e230. - PMC - PubMed
    1. Sofuoglu M, Yoo S, Hill KP, Mooney M. Self-administration of intravenous nicotine in male and female cigarette smokers. Neuropsychopharmacology. 2008;33:715–720. Although nicotine is the main addictive chemical in tobacco, there have been few studies of pure nicotine self-administration in humans. This study showed that smokers self-administer intravenous nicotine doses that are within the range of those of average intake from cigarette smoking. This model may be useful in the evaluation of the effects of both behavioral and pharmacologic manipulations on nicotine self-administration in humans. - PubMed

Publication types